NCT02209155View on ClinicalTrials.gov

R-Verapamil for the Prophylaxis of Episodic Cluster Headache

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Episodic Cluster Headache
Interventions
DRUG

R-verapamil 75 mg tablet

DRUG

Placebo

Trial Locations (1)

NW1 2BU

UCLH/UCL NIHR Clinical Research Facility, London

Sponsors
All Listed Sponsors
lead

Center Laboratories, Inc.

INDUSTRY

NCT02209155 - R-Verapamil for the Prophylaxis of Episodic Cluster Headache | Biotech Hunter | Biotech Hunter